Article
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.
PLoS pathogens - 1 Jul 2018
Bristol Jillian A, Djavadian Reza, Albright Emily R, Coleman Carrie B, Ohashi Makoto, Hayes Mitchell, Romero-Masters James C, Barlow Elizabeth A, Farrell Paul J, Rochford Rosemary, Kalejta Robert F, Johannsen Eric C, Kenney Shannon C
Abstract excerpt
Latent Epstein-Barr virus (EBV) infection contributes to both B-cell and epithelial-cell malignancies. However, whether lytic EBV infection also contributes to tumors is unclear, although the association between malaria infection and Burkitt lymphomas (BLs) may involve excessive lytic EBV replication. A particular variant of the viral promoter (Zp) that controls lytic EBV reactivation is over-represented,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
